WSL
ABVX

Western Standard LLC’s Abivax ABVX Stock Holding History

Western Standard LLC’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.7M Buy
+200,000
New +$22.6M 9.03% 4

Other funds holding ABVX

NNPTE
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne Warszawa, Poland $1.83B AUM 331.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
ACL
APEIRON Capital Ltd Hong Kong $156M AUM 183.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM

Western Standard LLC's ABVX Position: Q2 2026 in Review

Western Standard LLC opened a new position in Abivax (ABVX) in Q2 2026: 200,000 shares worth $26.7M. The stake represents 9.03% of the portfolio and ranks #4 among its holdings.

111 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Western Standard LLC held 200,000 shares of Abivax worth $26.7M as of Q2 2026.
  • Abivax was a new Western Standard LLC position in Q2 2026.
  • Abivax made up 9.03% of Western Standard LLC's portfolio in Q2 2026, its #4 holding.
  • 111 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Western Standard LLC's 13F filing for Q2 2026, filed 10 Aug 2026.